Investor Relations NEWS

2015.02.04 BioServe 25th Anniversary Message

BioServe 25th Anniversary Message

2015.02.02 ReproCELL Launches Sales Collaboration with DreamCell Co., Ltd. in Republic of Korea

ReproCELL Launches Sales Collaboration with DreamCell Co., Ltd. in Republic of Korea

2015.01.27 A national patent on culture method of hematopoietic stem cell was approved

A national patent on culture method of hematopoietic stem cell was approved

2014.11.04 Commencement of mutual sales of products from the ReproCELL group companies

Commencement of mutual sales of products from the ReproCELL group companies

2014.10.03 ReproCELL Completed the Acquisition of iPS Cell Business Unit of Stemgent, Inc.

ReproCELL Completed the Acquisition of iPS Cell Business Unit of Stemgent, Inc.(PDF)

2014.09.29 ReproCELL Launches the Operation of Cell Innovation Partners, L.P., Corporate Venture Capital Fund, with Shinsei Bank, Limited

ReproCELL Launches the Operation of Cell Innovation Partners, L.P., Corporate Venture Capital Fund, with Shins […]

2014.09.08 ReproCELL Acquires the iPS Cell Business Unit of Stemgent, Inc.

ReproCELL Acquires the iPS Cell Business Unit of Stemgent, Inc.

2014.08.04 ReproCELL Expects Synergy and Business Benefits through the Acquisitions of Reinnervate and BioServe

ReproCELL Expects Synergy and Business Benefits through the Acquisitions of Reinnervate and BioServe

2014.07.08 ReproCELL Inc. announces business collaboration with KOKEN CO., LTD

Yokohama, Kanagawa, Japan ReproCELL Inc. (ReproCELL, CEO: Chikafumi Yokoyama, Ph.D. JASDAQ: 4978) announced to […]

2014.07.08 ReproCELL supports CTSI Stem Cell Core Retreat on Jul 21, 2014.

ReproCELL supports CTSI Stem Cell Core Retreat as an official sponsor on Jul 21, 2014. – Flyer – P […]